September 3, 2024Open Access

Supplementary Figure S3 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Key points are not available for this paper at this time.

Supplementary Figure S3. Overall survival in the randomized cohorts.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Robert W. Lentz

Tyler J. Friedrich

Patrick J. Blatchford

Building similarity graph...

Analyzing shared references across papers